Medications for Psoriatic Arthritis
146 results
Abrilada (adalimumab-afzb)
(adalimumab-afzb)Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients 2 years and older.
Acthar (repository corticotropin)
(Repository Corticotropin)Mallinckrodt ARD LLC
Usage: Acthar Gel is indicated for treating infantile spasms in children under 2, acute exacerbations of multiple sclerosis in adults, and as adjunctive therapy for various rheumatic disorders, collagen diseases, severe dermatologic and allergic conditions, certain ophthalmic diseases, symptomatic sarcoidosis, and to manage nephrotic syndrome.
Adalimumab (adalimumab)
(adalimumab)Golden State Medical Supply, Inc.
Usage: Adalimumab-fkjp is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa. It reduces symptoms, inhibits structural damage progression, and improves physical function in affected patients.
Amjevita (adalimumab-atto)
(adalimumab-atto)Optum Health Solutions (Ireland) Limited
Usage: AMJEVITA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis. It can be used alone or with other therapies.
Amjevita (adalimumab-atto)
(adalimumab-atto)Amgen Inc
Usage: AMJEVITA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients. It can be used alone or with DMARDs.
Avsola (infliximab-axxq)
(infliximab-axxq)Amgen Inc
Usage: AVSOLA is indicated for treating moderately to severely active Crohn's disease and ulcerative colitis in adults and pediatric patients (6+ years), along with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis in adults, particularly for those who have inadequate responses to conventional therapies.
Baycadron (dexamethasone)
(Dexamethasone)Wockhardt USA, LLC
Usage: This drug is indicated for various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., arthritis), collagen diseases, dermatologic diseases, severe allergic reactions, ophthalmic inflammation, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and special cases like tuberculous meningitis and trichinosis.
Beta 1 kit (betamethasone sodium phosphate, betamethasone acetate)
(Betamethasone Sodium Phosphate, Betamethasone Acetate)Oaklock, LLC
Usage: Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated for severe allergic conditions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neurologic conditions, and various inflammatory diseases. It serves as adjunctive therapy for specific acute episodes and can be used intramuscularly, intra-articularly, or intralesionally.
Cosentyx (secukinumab)
(secukinumab)Novartis Pharmaceuticals Corporation
Usage: COSENTYX® is indicated for the treatment of moderate to severe plaque psoriasis in patients 6 years and older, active psoriatic arthritis in patients 2 years and older, ankylosing spondylitis in adults, non-radiographic axial spondyloarthritis in adults, active enthesitis-related arthritis in patients 4 years and older, and moderate to severe hidradenitis suppurativa in adults.
Cyltezo (adalimumab-adbm)
(adalimumab-adbm)Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: CYLTEZO is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients, either alone or with other therapies.
- ...